Michel Nakache has been brought on by McCann Healthcare Worldwide as EVP Europe. Nakache replaces McCann employee Mark Worman, who is returning to Australia. Most recently, Nakache held the position of worldwide managing partner, chairman EMEA/APAC, and chairman global brands of Havas Worldwide Health and Euro RSCG Life. The new EVP has more than 30 years of experience in pharma and healthcare communications, on both the client and agency sides of the business, including roles with Searle, GlaxoSmithKline, and Ogilvy Zoe Medical, to name a few.
EMD Serono, Inc., an affiliate of German pharma company Merck KGaA, has announced the appointment of James Hoyes to president of the biopharma company. Hoyes will be responsible for managing the day-to-day business of the US affiliate of Merck KGaA, as well as driving the direction of the company’s US commercial business, and he will serve as a member of the executive management board for Merck Serono. Prior to this position, Hoyes held the title of chief commercial officer at EMD Serono, and was responsible for business operations in the company’s key therapeutic areas of neurodegenerative diseases, rheumatology, fertility and metabolic endocrinology, as well as managed care, business intelligence, health outcomes, specialty pharmacy and commercial operations.
